Nehal Aly Afifi

Nehal Aly Afifi

Auto-generated profile, based on publicly available information

Nehal Aly Afifi

Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, 12211 Giza, Egypt

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1997 in British Poultry Science
Verified
Journal Article
Closed access
NAN. A. Afifi
N. A. Afifi
Khaled Abo-EL-SooudKhaled Abo-EL-Sooud
Khaled Abo-EL-Sooud
1. Florfenicol (30 mg/kg body weight) was administered to broiler chickens via intravenous (iv), intramuscular (im) and oral routes to study its plasma concentrations, kinetic behaviour, systemic bioavailability and tissue content. 2. Following a single iv injection, the kinetic disposition of florfenicol followed a 2‐compartmental open model with an elimination half‐life of 173 min, total body clearance of 26.9 ml/kg/min and a steady state volume of distribution of 5.11 1/kg. 3. The highest plasma concentrations of florfenicol were 3.82 and 3.20 μg/ml following single im and oral administration, respectively. The systemic bioavailability was 96.6% and 55.3% after im and oral administration. The plasma protein binding of florfenicol was 18.5%. 4. Following its administration, the highest tissue concentrations of the drug were found in the kidney bile, lung, muscle, intestine, heart, liver, spleen and plasma. Low concentrations of the drug were found in brain, bone marrow and fat. No florfenicol residues were detected in tissues and plasma after 72 h except in the bile from where it disappeared after 96 h.

1 June 2018 in Canadian Journal of Physiology and Pharmacology
Verified
Journal Article
Closed access
NANehal A. Afifi
Nehal A. Afifi
MIMarwa Ibrahim
Marwa Ibrahim
MGMona K. Galal
Mona K. Galal
Despite all the studies performed to date, therapy choices for liver injuries are very few. Therefore, the search for a new treatment that could safely and effectively block or reverse liver injuries remains a challenge. Quercetin (QR) and ellagic acid (EA) had potent antioxidant and anti-inflammatory activities. The current study aimed at evaluating the potential hepatoprotective influence of QR and EA against thioacetamide (TAA)-induced liver toxicity in rats and the underlying mechanism using silymarin as a reference drug. Fifty mature male rats were orally treated daily with EA and QR in separate groups for 45 consecutive days, and then were injected with TAA twice with 24 h intervals in the last 2 days of the experiment. Administration of TAA resulted in marked elevation of liver indices, alteration in oxidative stress parameters, and significant elevation in expression level of fibrosis-related genes (MMP9 and MMP2). Administration of QR and EA significantly attenuated the hepatic toxicity through reduction of liver biomarkers, improving the redox status of the tissue, as well as hampering the expression level of fibrosis-related genes. In this study, QR and EA were proved to attenuate the hepatotoxicity through their antioxidant, metal-chelating capacity, and anti-inflammatory effects.

1 August 2019 in Journal of Chromatography A
Verified
Journal Article
Closed access
XMXingbin Ma
Xingbin Ma
HLHongling Lin
Hongling Lin
YHYahui He
Yahui He
YSYongxin She
Yongxin She
MWMiao Wang
Miao Wang
JZJiyu Zhang
Jiyu Zhang

1 May 1994 in Fish & Shellfish Immunology
Verified
Journal Article
Closed access
ARA. Ramadan
A. Ramadan
NANehal A. Afifi
Nehal A. Afifi
MMM.M. Moustafa
M.M. Moustafa
ASA.M. Samy
A.M. Samy

1 June 2018 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
ARA. Ramadan
A. Ramadan
NANehal Afifi
Nehal Afifi
NYNemat Z. Yassin
Nemat Z. Yassin
Rehab Fawzy Abdel-RahmanRehab Fawzy Abdel-Rahman
Rehab Fawzy Abdel-Rahman
Sahar S Abd El-RahmanSahar S Abd El-Rahman
Sahar S Abd El-Rahman
HFHany M Fayed
Hany M Fayed

1 April 2017 in Canadian Journal of Physiology and Pharmacology
Verified
Journal Article
Closed access
NANehal A. Afifi
Nehal A. Afifi
ARAmer Ramadan
Amer Ramadan
EEEmad Y. Erian
Emad Y. Erian
DSDalia O. Saleh
Dalia O. Saleh
ASAhmed A. Sedik
Ahmed A. Sedik
WEW. El-Hotaby El-Hotaby
W. El-Hotaby El-Hotaby
The present study aimed to evaluate the effect of trigonelline (TRG) on the hepatic complications associated with high-fat high-fructose (HFHF) diet-induced insulin resistance (IR) in rats. IR was induced by giving a saturated fat diet and 10% fructose in drinking water to rats for 8 weeks. Insulin-resistant rats were orally treated with TRG (50 and 100 mg/kg), sitagliptin (SIT; 5 mg/kg), or a combination of TRG (50 mg/kg) and SIT (5 mg/kg) for 14 days. Liver homogenates were used for assessment of hepatic lipids, oxidative stress biomarkers, and inflammatory cytokines. Histopathological and DNA cytometry examinations were carried out for hepatic and pancreatic tissues. Hepatic tissues were examined using Fourier-transform infrared spectroscopy for assessment of any molecular changes. Results of the present study revealed that oral treatment of insulin-resistant rats with TRG or TRG in combination with SIT significantly decreased homeostatic model assessment of IR, hepatic lipids, oxidative stress biomarkers, and the inflammatory cytokines. TRG or TRG in combination with SIT ameliorated the histopathological, DNA cytometry, and molecular alterations induced by a HFHF diet. Finally, it can be concluded that TRG has beneficial effects on the hepatic complications associated with IR due to its hypoglycemic effect and antioxidant potential.